PAA 2.94% 16.5¢ pharmaust limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-632

  1. 12,034 Posts.
    lightbulb Created with Sketch. 6153
    Great write up thank you ,,, only part for me still lacking is NOT "Tell the Story" But "Sell the Story" on the cusp of multiple trials ,, company need a professional to inform the market of the commercial opportunities provided by Pharmaust.
    Covid has ravaged businesses and caused financial distress to many . not so much courage to sell low but necessity Q.... interest rates are rising so options are crystalising for investors,,, over here in NZ Mortgage rates are climbing steeply .... PAA just haven't been able to impart Value, still tagged with Research Institute label,,I believe this will take outside professional assistance to change the markets perception.

    Question to the BOD "why is PAA the only Phase II Oncology company valued below $100m MC"? with so many offerings not just Cancer?

    Need to get those oppies in the Money , with only 3 Q of operating Capital and the ASX regs are min 2 Q operating capital... even if they dont hit the 21c mark a small CR up in the high teens has to be better than 8 or 9 cents...
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.5¢
Change
-0.005(2.94%)
Mkt cap ! $80.22M
Open High Low Value Volume
17.0¢ 18.0¢ 16.5¢ $210.6K 1.236M

Buyers (Bids)

No. Vol. Price($)
2 274938 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 15000 2
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.